Title:
USP1 INHIBITOR
Document Type and Number:
WIPO Patent Application WO/2024/046471
Kind Code:
A1
Abstract:
The present application provides a class of novel compounds having a USP1 inhibitory activity as shown in formula (II'), pharmaceutical compositions comprising the compounds, useful intermediates for preparing the compounds, and a method for treating related diseases mediated by a USP1 target by means of the compounds of the present application.
Inventors:
QIN HUA (CN)
SHI GUQIN (CN)
ZHANG YUXING (CN)
XU YIMING (CN)
HAO JUNGUO (CN)
CHEN XU (CN)
FENG HAO (CN)
ZHU PANHU (CN)
FU JIASHENG (CN)
SUN WEIMEI (CN)
SUN DAQING (CN)
SHI GUQIN (CN)
ZHANG YUXING (CN)
XU YIMING (CN)
HAO JUNGUO (CN)
CHEN XU (CN)
FENG HAO (CN)
ZHU PANHU (CN)
FU JIASHENG (CN)
SUN WEIMEI (CN)
SUN DAQING (CN)
Application Number:
PCT/CN2023/116528
Publication Date:
March 07, 2024
Filing Date:
September 01, 2023
Export Citation:
Assignee:
SHANGHAI QILU PHARMACEUTICAL RES AND DEVELOPMENT CENTRE LTD (CN)
International Classes:
C07D487/04; A61K31/519; A61K31/52; A61K45/06; A61P35/00; C07D513/14; C07D519/00
Domestic Patent References:
| WO2022228399A1 | 2022-11-03 | |||
| WO2022174184A1 | 2022-08-18 |
Foreign References:
| CN113164485A | 2021-07-23 |
Attorney, Agent or Firm:
PATENTSINO IP FIRM (CN)
Download PDF: